Levocarnitine Tablet
Product Images NDC 16571-762

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Levocarnitine (NDC 16571-762). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rising Pharma Holdings, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Levocarnitine-carton-label (Levocarnitine Carton Label)

Levocarnitine-carton-label (Levocarnitine Carton Label)
This is a medication called Levocarnitine in the form of tablets. Each tablet contains 330mg of Levocamitine, USP. In order to obtain information regarding dosage, it is recommended to consult a physician. The package should be stored in a controlled temperature environment, between 20°C to 25°C. This package is not child-resistant, hence the owner must ensure that it is kept out of the reach of children. This medication is also manufactured by Gravii Pharmaceuticals Prats Limtad in Tolangana, India and is supplied and distributed by Rising Pharma Holdings, Inc. located in East Brunswick, NJ 08316.*
FDA Label Image

Levocarnitine-struc (Levocarnitine Struc)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.